Olivier Bergis

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2006 · 237 citations

Medicine, Neuroscience, Pharmacology +13

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Bruno Biton, Olivier Bergis, Frédéric Galli et al. · Neuropsychopharmacology · 2006 · 175 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2007 · 117 citations

Medicine, Pharmacology, Psychiatry +14

SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Caroline Cohen, Olivier Bergis, Francesco Galli et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 114 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

Guy Griebel, Philippe Pichat, Sandra Beeské et al. · Scientific Reports · 2015 · 110 citations · Full text

Medicine, Neuroscience, Pharmacology +17